AI Assessment Reveals Gaps in Global Cancer Control Plans
A new study highlights significant variations in the comprehensiveness of National Cancer Control Plans across 50 countries, emphasizing the need for improved financing and outcome measurement.
The median comprehensiveness score for cancer control plans is 2.78 out of 5.
European nations scored highest, while the Western Pacific region lagged behind.
Sustainable financing and measurable outcomes are critical for enhancing cancer policy effectiveness.
A recent assessment utilizing artificial intelligence has uncovered notable disparities in the comprehensiveness of National Cancer Control Plans (NCCPs) across 50 countries. The study, which employed the policy reasoning integrated sequential model (PRISM), revealed that areas such as financing, outcome measurement, and contextual analysis were particularly lacking. This research underscores the potential for enhancing cancer policy development through standardized evaluations and scalable analytical methods.
The assessment involved identifying the most recent NCCP for each participating country, drawing from international databases and government resources. Researchers constructed a comprehensive analytical framework that included 12 primary elements and 76 sub-elements, guided by international cancer control recommendations. This framework underwent validation through a two-stage Delphi process, which included an online survey of 67 experts and a workshop with 31 participants, ensuring its robustness and relevance.
The findings indicated that the overall median comprehensiveness score for the NCCPs was 2.78 on a five-point scale, reflecting moderate performance. European countries achieved the highest median score of 2.96, while the Western Pacific region recorded the lowest at 2.21. Among different income classifications, lower-middle-income countries scored the highest median at 2.97, contrasting with a mere 2.05 for low-income countries. Notably, implementation scored the highest individual element median at 4.17, while financing and outcomes lagged significantly behind, with scores of 1.88 and 1.83, respectively.
The implications of these findings are significant for global cancer policy. The researchers advocate for increased focus on sustainable financing, measurable outcomes, and contextual factors to enhance the comprehensiveness of national cancer strategies. They propose that frameworks for shared health systems and scalable AI tools like PRISM could facilitate more consistent comparisons among countries, enabling policymakers to develop timely and evidence-based cancer control plans that reflect the latest data.
Looking ahead, the study suggests that rapid appraisal methods could be instrumental in guiding policymakers toward creating effective and context-specific cancer control strategies. The ongoing development and refinement of such assessment tools will be crucial in addressing the identified gaps and improving cancer care worldwide.




